Related Experiment Video
Updated: Jul 1, 2026
09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
16.7K
Overview of dendritic cell-based vaccine development for leishmaniasis
M Bagirova1, A M Allahverdiyev2, E S Abamor1
1Bioengineering Department, Yildiz Technical University, Esenler, Istanbul, Turkey.
Parasite Immunology
|September 4, 2016
Summary
Current leishmaniasis vaccines have significant side effects and offer unreliable protection. Research is exploring dendritic cells (DCs) stimulated with Leishmania antigens as a promising new vaccine strategy against this global vector-borne disease.
Area of Science:
- Immunology
- Tropical Medicine
- Vaccinology
Background:
- Leishmaniasis is a severe vector-borne disease affecting 350 million people globally.
- Existing vaccines exhibit limited efficacy, undesirable side effects, and lack reliable protection.
- There is a critical need for safe and effective leishmaniasis vaccines.
Purpose of the Study:
- To review current challenges in leishmaniasis vaccine development.
- To explore the role of dendritic cells (DCs) in leishmaniasis immunopathogenesis.
- To consolidate recent findings on DC-based vaccine strategies for leishmaniasis.
Main Methods:
- Review of existing literature on leishmaniasis vaccines.
- Analysis of the immunological functions of dendritic cells (DCs).
- Examination of studies utilizing Leishmania antigen-stimulated DCs in vaccine development.
Main Results:
- Previous vaccine generations for leishmaniasis have shown limited success.
- Dendritic cells (DCs) possess unique antigen-presenting capabilities relevant to immunity.
- Studies using DCs stimulated with Leishmania antigens have yielded promising preliminary results.
Conclusions:
- Dendritic cells (DCs) represent a promising avenue for developing novel leishmaniasis vaccines.
- Further research into DC-based immunotherapies is warranted to overcome current vaccine limitations.
- Understanding DC function is crucial for advancing leishmaniasis control strategies.
More Related Videos
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...